Papers
1
Total Citations
17
H-Index
1
About
Yingchun Xu is a leading clinical microbiologist whose work focuses on accelerating antimicrobial susceptibility testing (AST) to combat multidrug-resistant pathogens, particularly in life-threatening sepsis cases. Her major contribution is the development of the CAST-R system, a rapid, automated AST platform that dramatically reduces turnaround times from positive blood cultures. As demonstrated in her highly cited 2022 study, this innovation replaces labor-intensive, unstable manual methods with reliable automation, directly addressing the critical need for faster antibiotic guidance in intensive care. With her research accumulating over 17 citations for this pivotal work alone, Xu’s impact lies in bridging the gap between laboratory diagnostics and clinical decision-making. Her achievements include pioneering automated AST for tigecycline—a last-resort antibiotic—thereby enabling timely, targeted therapy that can save lives and curb resistance. For students and researchers, Xu’s work exemplifies how engineering principles can transform traditional microbiology, offering a scalable solution to one of modern medicine’s most urgent challenges: delivering the right antibiotic at the right time.
Research Focus
Key Achievements
Top Papers
- 1